Liguori, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 1.303
AS - Asia 1.273
EU - Europa 1.061
SA - Sud America 274
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.956
Nazione #
US - Stati Uniti d'America 1.259
SG - Singapore 650
CN - Cina 311
BR - Brasile 231
DE - Germania 225
IT - Italia 216
SE - Svezia 199
IE - Irlanda 82
GB - Regno Unito 68
FR - Francia 66
VN - Vietnam 56
ID - Indonesia 52
IN - India 47
FI - Finlandia 44
RU - Federazione Russa 30
CA - Canada 27
KR - Corea 26
HK - Hong Kong 25
BD - Bangladesh 21
BE - Belgio 21
AR - Argentina 18
AT - Austria 17
PL - Polonia 17
ES - Italia 14
ZA - Sudafrica 14
TR - Turchia 13
CZ - Repubblica Ceca 12
IQ - Iraq 11
JP - Giappone 11
NL - Olanda 10
PK - Pakistan 10
UA - Ucraina 10
CH - Svizzera 8
CI - Costa d'Avorio 7
EG - Egitto 7
IR - Iran 7
MX - Messico 7
RO - Romania 6
SA - Arabia Saudita 6
CL - Cile 5
DZ - Algeria 5
EC - Ecuador 5
JO - Giordania 5
CO - Colombia 4
LT - Lituania 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
LB - Libano 3
PH - Filippine 3
TT - Trinidad e Tobago 3
DK - Danimarca 2
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
HU - Ungheria 2
IS - Islanda 2
JM - Giamaica 2
KE - Kenya 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
UY - Uruguay 2
UZ - Uzbekistan 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HT - Haiti 1
KG - Kirghizistan 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
Totale 3.956
Città #
Singapore 337
New York 151
Ashburn 149
Chandler 136
Frankfurt am Main 136
Dublin 82
Beijing 78
Hefei 77
Rome 67
Dallas 62
Chicago 53
Jakarta 48
Los Angeles 42
The Dalles 39
Munich 31
Milan 30
Helsinki 29
Seoul 26
Hong Kong 25
Moscow 24
Ho Chi Minh City 23
São Paulo 22
Brussels 21
Kent 21
Boston 17
Brooklyn 17
Castelnuovo di Val di Cecina 17
Princeton 14
San Mateo 14
Santa Clara 13
Atlanta 12
Nuremberg 12
Brno 11
Denver 11
Marseille 11
Palermo 11
Hyderabad 10
London 10
Poplar 10
Turku 10
Wilmington 10
Bremen 9
Düsseldorf 9
Falls Church 9
Hanoi 9
Johannesburg 9
Dhaka 8
Rio de Janeiro 8
Tokyo 8
Toronto 8
Warsaw 8
Abidjan 7
Augusta 7
Buffalo 7
Montreal 7
North Bergen 7
Seattle 7
Vienna 7
Zurich 7
Baghdad 6
Curitiba 6
Lauterbourg 6
Norwalk 6
Roubaix 6
Amman 5
Belo Horizonte 5
Bexley 5
Boardman 5
Campinas 5
Chennai 5
Houston 5
Lappeenranta 5
Manchester 5
Orem 5
Shanghai 5
Washington 5
Wroclaw 5
Council Bluffs 4
Falkenstein 4
Genoa 4
Guarulhos 4
Kish 4
Mumbai 4
Ottawa 4
Portland 4
Portsmouth 4
Pune 4
San Francisco 4
San Jose 4
Ankara 3
Biên Hòa 3
Cairo 3
Calgary 3
Charlotte 3
Cincinnati 3
Da Nang 3
Duque de Caxias 3
Fortaleza 3
Istanbul 3
Karachi 3
Totale 2.236
Nome #
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? 227
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 153
Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues 141
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 132
Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1) 131
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 124
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 120
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 118
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 103
The role of elastography in non-Alcoholic fatty liver disease 103
Acute HEV hepatitis: clinical and laboratory diagnosis 95
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 93
Clinical impact of comorbidities in an Italian NAFLD cohort 90
URINARY LITHOGENIC PROFILE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 89
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 89
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 83
Correlation of the transaminases alteration with the clinical severity of patients with COVID-19: A meta-analysis of the first global outbreak 82
Fib-4 score is able to predict intra-hospital mortality in 4 different SARS-COV2 waves 81
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 81
Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs 79
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 78
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 78
Reasons for Tooth Extractions and Related Risk Factors in Adult Patients: A Cohort Study 77
Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease 77
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: preva-lence of advanced liver fibrosis among Italian primary care pa-tients with NAFLD 76
Increased serum ferritin levels predict long-term mortality in patients with NAFLD 76
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 75
Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease. An international study in non-cirrhotic, biopsy-proven patients 74
Gallbladder perforation without cholecystitis in a patient awaiting liver transplantation: a peculiar case report of anaemia in cirrhosis 74
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 73
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 72
Non-alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services: GPS-NAFLD Study 70
Liver stiffness in the early post-liver transplant phase as a marker of acute allograft rejection 68
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) 68
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 65
FREQUENCY AND REASONS FOR NON-LISTING IN REFERRED ADULT PATIENTS FOR LIVER TRANSPLANTATION 64
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease 64
FREQUENCY OF AND REASONS BEHIND NON-LISTING IN ADULT PATIENTS REFERRED FOR LIVER TRANSPLANTATION 63
Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease: An international study in non-cirrhotic, biopsy-proven patients 59
Nonalcoholic fatty liver disease (Nafld) as model of gut–liver axis interaction: From pathophysiology to potential target of treatment for personalized therapy 58
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease 58
Steatohepatitis and type 2 diabetes mellitus are influenced by genetic susceptibility to increased intestinal permeability in patients with non-alcoholic fatty liver disease 57
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women 56
Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non-Alcoholic Fatty Liver Disease. a Longitudinal International Study 50
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease 49
HEPATOMA ARTERIAL-EMBOLISATION PROGNOSTIC SCORE PREDICTS PROGRESSION IN HEPATOCELLULAR CARCINOMA TREATED BY RADIOFREQUENCY ABLATION PLUS TRANSARTERIAL CHEMOEMBOLIZATION 49
TACROLIMUS BLOOD-BILE RATIO FOR THE EARLY DETECTION OF THE REJECTION GRAFT INJURY AFTER LIVER TRANSPLANTATION 44
Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non-Alcoholic Fatty Liver Disease. a Longitudinal International Study 38
Totale 4.024
Categoria #
all - tutte 20.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 1 5 9 3 5 22 0
2021/2022148 5 1 5 19 15 9 3 27 8 4 26 26
2022/2023616 56 47 23 54 77 90 55 47 50 40 55 22
2023/2024565 45 143 26 35 26 81 51 17 8 40 28 65
2024/20251.048 20 5 90 37 78 42 28 53 129 123 234 209
2025/20261.560 348 64 195 340 354 259 0 0 0 0 0 0
Totale 4.024